CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.

Luciana Teofili, Immacolata Izzi, Eugenia Rosa Nuzzolo, Giancarlo Scoppettuolo, Katleen de Gaetano Donati, Lorenza Torti, Marianna Rossi
  • Immacolata Izzi
    Affiliation not present
  • Eugenia Rosa Nuzzolo
    Affiliation not present
  • Giancarlo Scoppettuolo
    Affiliation not present
  • Katleen de Gaetano Donati
    Affiliation not present
  • Lorenza Torti
    Affiliation not present
  • Marianna Rossi
    Affiliation not present

Abstract

We retrospectively compared the incidence of neutropenia  in two groups of  HIV patients with lymphoma,  who underwent chemotherapy supported by once-per-cycle administration of pegfilgrastim or by daily subcutaneous injection of filgrastim, respectively. Our findings indicate that pegfilgrastim and filgastrim produce similar results in preventing both neutropenia and febrile neutropenia.

Keywords

Lymphoma; HIV

Full Text:

PDF
HTML
Submitted: 2014-06-13 09:32:07
Published: 2012-10-03 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
139

Views:
PDF
106
HTML
1108

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.
 
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185